Related Experiment Video
Updated: Mar 17, 2026

08:18
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
3.5K
Significantly high lymphatic vessel density in cutaneous metastasizing melanoma
1Department of Nuclear Medicine and Thyroid Diseases, Clinical Centre Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
Hippokratia
|July 16, 2016
Summary
Higher lymphatic vessel density (LVD) in melanomas indicates a greater risk of metastasis. This study found increased LVD in metastasizing melanomas compared to non-metastasizing ones and nevi, particularly in thicker tumors.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Cutaneous melanoma frequently metastasizes via lymphatic vessels.
- Increased tumor-associated lymphatics correlate with lymph node metastasis.
- Lymphatic vessel density (LVD) in melanoma requires further investigation.
Purpose of the Study:
- To compare LVD in metastasizing melanomas versus non-metastasizing melanomas and nevi.
- To determine if LVD differs based on melanoma metastatic potential.
- To assess LVD as a potential indicator of melanoma metastasis risk.
Main Methods:
- Immunostaining of 95 melanoma and 22 nevus specimens using D2-40.
- Computer-assisted morphometric analysis for LVD quantification.
- Matching melanoma specimens by thickness (≤2.0 mm, 2.01-4.0 mm, >4.0 mm).
Main Results:
- Metastasizing melanomas (2.01-4.0 mm and >4.0 mm) showed significantly higher intratumoral and peritumoral LVD than non-metastasizing melanomas.
- No significant LVD difference was observed in melanomas ≤2.0 mm thickness.
- Metastasizing melanomas exhibited significantly higher LVD than all types of nevi.
Conclusions:
- Higher LVD is observed in metastasizing melanomas compared to non-metastasizing melanomas and nevi.
- Increased intratumoral and peritumoral LVD in intermediate and thick melanomas correlates with lymph node metastasis.
- LVD serves as a potential biomarker for identifying melanomas at higher risk of metastasis.

